| scholarly article | Q13442814 |
| P2093 | author name string | Julie D Saba | |
| Youn-Jeong Choi | |||
| P2860 | cites work | Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1) | Q24290363 |
| Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 | Q24336131 | ||
| The sphingolipid salvage pathway in ceramide metabolism and signaling | Q24642219 | ||
| Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond | Q27011857 | ||
| Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism | Q27664005 | ||
| The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase | Q27930762 | ||
| The Sjögren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway. | Q27933383 | ||
| Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast | Q28261678 | ||
| Principles of bioactive lipid signalling: lessons from sphingolipids | Q28265743 | ||
| Essential role for sphingosine kinases in neural and vascular development | Q28505987 | ||
| The PDGF signaling pathway controls multiple steroid-producing lineages | Q28587022 | ||
| PDGF signaling specificity is mediated through multiple immediate early genes | Q28593571 | ||
| Sphingosine 1-phosphate lyase ablation disrupts presynaptic architecture and function via an ubiquitin- proteasome mediated mechanism. | Q30829642 | ||
| SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production | Q30853652 | ||
| Genetic testing in steroid-resistant nephrotic syndrome: when and how? | Q33361808 | ||
| Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions | Q33396938 | ||
| Protein misfolding and degradation in genetic diseases. | Q33728820 | ||
| Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. | Q33773569 | ||
| Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver | Q33796272 | ||
| A prokaryotic S1P lyase degrades extracellular S1P in vitro and in vivo: implication for treating hyperproliferative disorders | Q33988392 | ||
| Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. | Q34229460 | ||
| Oxysterol binding protein-dependent activation of sphingomyelin synthesis in the golgi apparatus requires phosphatidylinositol 4-kinase IIα. | Q34360965 | ||
| An update on sphingosine-1-phosphate and other sphingolipid mediators | Q34402916 | ||
| Oral fingolimod (FTY720) for relapsing multiple sclerosis | Q34565985 | ||
| Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. | Q34606305 | ||
| Sphingosine-1-phosphate receptors and the development of the vascular system | Q34691550 | ||
| Phosphatidylethanolamine positively regulates autophagy and longevity | Q35079520 | ||
| Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs | Q35145464 | ||
| Ceramide-rich platforms in transmembrane signaling | Q35633883 | ||
| Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania | Q35752867 | ||
| HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation | Q35862820 | ||
| Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant | Q35977167 | ||
| Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues | Q36145233 | ||
| Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling | Q36284042 | ||
| Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis | Q36422392 | ||
| Immunohistochemical analysis of sphingosine phosphate lyase expression during murine development | Q36581831 | ||
| Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. | Q36627430 | ||
| Sply regulation of sphingolipid signaling molecules is essential for Drosophila development | Q44408457 | ||
| Substrate reduction intervention by L-cycloserine in twitcher mice (globoid cell leukodystrophy) on a B6;CAST/Ei background | Q44514406 | ||
| Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients | Q46265539 | ||
| Degradation of sphingoid long-chain base 1-phosphates (LCB-1Ps): functional characterization and expression of AtDPL1 encoding LCB-1P lyase involved in the dehydration stress response in Arabidopsis. | Q46320194 | ||
| Ceramide Is Metabolized to Acylceramide and Stored in Lipid Droplets | Q47951459 | ||
| S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling | Q48247517 | ||
| Steroid-resistant nephrotic syndrome: past and current perspectives | Q49500608 | ||
| Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications. | Q50456678 | ||
| Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease. | Q51732049 | ||
| A novel mutation in sphingosine-1-phosphate lyase causing congenital brain malformation. | Q52675937 | ||
| Sphingosine-1-phosphate receptors and innate immunity. | Q52677659 | ||
| Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation. | Q53633118 | ||
| Biphasic regulation of type II phosphatidylinositol-4 kinase by sphingosine: cross talk between glycero- and sphingolipids in the kidney. | Q54388822 | ||
| Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss | Q57399036 | ||
| Sphingolipid hydrolyzing enzymes in the gastrointestinal tract | Q73186737 | ||
| Adrenal insufficiency in association with congenital nephrotic syndrome: a case report | Q87451003 | ||
| Sphingosine 1-phosphate and cancer | Q89059771 | ||
| Sphingolipids and neuronal degeneration in lysosomal storage disorders | Q89360246 | ||
| Nephrotic syndrome and adrenal insufficiency caused by a variant in SGPL1 | Q90845514 | ||
| Sphingosine-1-phosphate regulation of mammalian development. | Q36924324 | ||
| Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons | Q37160896 | ||
| Ceramide kinase and the ceramide-1-phosphate/cPLA2alpha interaction as a therapeutic target | Q37239622 | ||
| Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease | Q37259737 | ||
| Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies | Q37382152 | ||
| Lyase to live by: sphingosine phosphate lyase as a therapeutic target | Q37414484 | ||
| Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress | Q37415213 | ||
| Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency | Q37672116 | ||
| Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome | Q37672138 | ||
| PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism | Q37895205 | ||
| Sphingosine-1-phosphate and its receptors: structure, signaling, and influence | Q38092862 | ||
| Disentangling biological signaling networks by dynamic coupling of signaling lipids to modifying enzymes | Q38157461 | ||
| The chaperone role of the pyridoxal 5'-phosphate and its implications for rare diseases involving B6-dependent enzymes. | Q38172732 | ||
| The therapeutic potential of chemical chaperones in protein folding diseases. | Q38211124 | ||
| Causes and pathogenesis of focal segmental glomerulosclerosis | Q38275115 | ||
| The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis | Q38347258 | ||
| Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism | Q38391849 | ||
| Recent advances and novel treatments for sphingolipidoses | Q38635135 | ||
| Unwinding focal segmental glomerulosclerosis | Q38685434 | ||
| The sphingosine 1-phosphate breakdown product, (2E)-hexadecenal, forms protein adducts and glutathione conjugates in vitro | Q38739843 | ||
| A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders | Q38802675 | ||
| Cholesterol interactions with ceramide and sphingomyelin. | Q38821945 | ||
| Epithelial cell extrusion: Pathways and pathologies. | Q38841415 | ||
| Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase | Q38976359 | ||
| Ceramidases, roles in sphingolipid metabolism and in health and disease | Q38988326 | ||
| Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy. | Q39026251 | ||
| Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis | Q39356027 | ||
| Characterization of secreted sphingosine-1-phosphate lyases required for virulence and intracellular survival of Burkholderia pseudomallei | Q39385841 | ||
| New developments in Charcot-Marie-Tooth neuropathy and related diseases | Q39415070 | ||
| A Legionella effector acquired from protozoa is involved in sphingolipids metabolism and is targeted to the host cell mitochondria. | Q39852238 | ||
| Therapeutic Gene Editing Safety and Specificity. | Q40045823 | ||
| The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate | Q40420944 | ||
| Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol. | Q40496768 | ||
| Sphingosine-phosphate lyase | Q40850218 | ||
| Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology | Q41328049 | ||
| Roles of sphingosine-1-phosphate signaling in angiogenesis | Q41812316 | ||
| The sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA. | Q42212613 | ||
| Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice. | Q43277471 | ||
| Sphingosine phosphate lyase expression is essential for normal development in Caenorhabditis elegans | Q44394459 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sphingolipids | Q410395 |
| P304 | page(s) | 128-140 | |
| P577 | publication date | 2018-09-25 | |
| P1433 | published in | Advances in Biological Regulation | Q26854003 |
| P1476 | title | Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism | |
| P478 | volume | 71 |
| Q93166960 | A Sphingosine-1-Phosphate Lyase Mutation Associated With Congenital Nephrotic Syndrome and Multiple Endocrinopathy |
| Q90328179 | S1P and plasmalogen derived fatty aldehydes in cellular signaling and functions |
| Q90280804 | SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency |
| Q92711711 | Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases |
Search more.